Pharmacologic vitreolysis

Pioneering enzymatic vitreolysis treatment for floaters

A 2007 scientific publication recently came to our attention, "Posterior vitreous detachment and pharmacologic vitreolysis: The New Era of enzymatic vitrectomy". It talked about the use of plasmin, a protease from the patient's own blood, as an adjunct 15 minutes prior to surgical vitrectomy to induce posterior vitreous detachment .

Syndicate content

Charity cards

Help raise the profile of eye floaters with One Clear Vision charity cards Christmas box sets now on sale. Visit the online shop.

Research survey

Please take 10 minutes to complete our online survey and add to our research base.

Get involved

One Clear Vision needs you. Find out how you can help.

English

Donate to OCV

Donate to One Clear Vision and help improve the prospects of sufferers of eye floaters

Members of VISION 2020 UK

One Clear Vision is a member of the umbrella group, VISION 2020 UK The Right to Sight

Physician Directory

View our list of ophthalmologists sympathetic to treating vitreous opacities

Poll

What would you be prepared to pay for an effective drug targeted at the symptomatic relief of floaters?
Up to $1000 per year
11%
$2000 per year
7%
$3000 per year
7%
Over $3000 per year
75%
Total votes: 28

Community

Be part of the worldwide eye floater community and add yourself to our world map
Whether you are a sufferer or an interested party, plant your flag on our worldwide map.

Eye on Floaters

Click below for the award winning Helen Keller video on eye floaters

Award winning Helen Keller video